Seed Bioinformatics Companies

The Woof provides a dog collar that includes a GPS tracker.

Enabling Safer Gene Editing

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

Pluto Biosciences develops a collaborative life sciences platform for biological data management, analysis, and visualization.

XAI Platform for Cancer Genomics Interpretation SaaS

The operating system for data science.

Network Bio's biomedical data for AI-enabled precision medicine

Evolvere BioSciences develops next-generation antibiotics using AI-driven co-evolutionary models to outpace bacterial resistance.

Bioplastix aims to produce biomaterials with outstanding properties, derived from renewable sources at competitive prices.

TeOra offers disease management and enhanced growth for plants and animals.

SaaS, biotech, dna, genomics, diagnostics

EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design.

Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.

Omica turns real-world clinical data into structured training infrastructure for biomedical AI

Applied Biosensors manufactures biosensors and life science products.

Cytocast revolutionizes the fields of drug discovery and personalized treatment through a comprehensive cell simulator.

IdentifAI Genetics revolutionizes the way prenatal testing is done.

Drift Bio develops software to help life sciences companies analyze their data.

ShanX Medtech is a medical diagnostics company that offers rapid in vitro diagnostic and antimicrobial susceptibility testing services.

Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases.

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.

Ligo Biosciences develops deep-learning models for enzyme design to reduce the cost of chemical manufacturing.

First-in-class predictive biomarkers to unlock antifibrotic therapy for breast cancer and beyond...

At 310 AI, our aim is to build the generative AI engine that will make programmable biology a reality.

Multi-Omics Driven Development of Effective Cell Therapies